These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8589705)

  • 1. Granin expectations in breast cancer?
    Steeg PS
    Nat Genet; 1996 Mar; 12(3):223-5. PubMed ID: 8589705
    [No Abstract]   [Full Text] [Related]  

  • 2. BRCA1 is secreted and exhibits properties of a granin.
    Jensen RA; Thompson ME; Jetton TL; Szabo CI; van der Meer R; Helou B; Tronick SR; Page DL; King MC; Holt JT
    Nat Genet; 1996 Mar; 12(3):303-8. PubMed ID: 8589722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of the amino-terminal zinc ring domain of BRCA1.
    Bienstock RJ; Darden T; Wiseman R; Pedersen L; Barrett JC
    Cancer Res; 1996 Jun; 56(11):2539-45. PubMed ID: 8653694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the BRCA1 gene in human cancer.
    Xu CF; Solomon E
    Semin Cancer Biol; 1996 Feb; 7(1):33-40. PubMed ID: 8695765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation functions in BRCA2.
    Milner J; Ponder B; Hughes-Davies L; Seltmann M; Kouzarides T
    Nature; 1997 Apr; 386(6627):772-3. PubMed ID: 9126734
    [No Abstract]   [Full Text] [Related]  

  • 6. Internal repeats in the BRCA2 protein sequence.
    Bork P; Blomberg N; Nilges M
    Nat Genet; 1996 May; 13(1):22-3. PubMed ID: 8673099
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.
    Liu J; Yuan Y; Huan J; Shen Z
    Oncogene; 2001 Jan; 20(3):336-45. PubMed ID: 11313963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [BRCA1 and BRCA2--breast cancer susceptibility genes].
    Dagan E; Gershoni-Baruch R
    Harefuah; 1997 Nov; 133(10):455-7. PubMed ID: 9418320
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
    De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
    Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 protein products ... Functional motifs..
    Koonin EV; Altschul SF; Bork P
    Nat Genet; 1996 Jul; 13(3):266-8. PubMed ID: 8673121
    [No Abstract]   [Full Text] [Related]  

  • 11. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
    Armes JE; Trute L; White D; Southey MC; Hammet F; Tesoriero A; Hutchins AM; Dite GS; McCredie MR; Giles GG; Hopper JL; Venter DJ
    Cancer Res; 1999 Apr; 59(8):2011-7. PubMed ID: 10213514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.
    Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E
    Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162
    [No Abstract]   [Full Text] [Related]  

  • 13. BRCA1. A new marker in the management of patients with breast cancer?
    Offit K
    Cancer; 1996 Feb; 77(4):599-601. PubMed ID: 8616748
    [No Abstract]   [Full Text] [Related]  

  • 14. [BRCA1 and cancer: a new lead].
    Larsen CJ
    Bull Cancer; 2000 Oct; 87(10):693-4. PubMed ID: 11185523
    [No Abstract]   [Full Text] [Related]  

  • 15. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
    Phelan CM; Rebbeck TR; Weber BL; Devilee P; Ruttledge MH; Lynch HT; Lenoir GM; Stratton MR; Easton DF; Ponder BA; Cannon-Albright L; Larsson C; Goldgar DE; Narod SA
    Nat Genet; 1996 Mar; 12(3):309-11. PubMed ID: 8589723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
    Neuhausen S; Gilewski T; Norton L; Tran T; McGuire P; Swensen J; Hampel H; Borgen P; Brown K; Skolnick M; Shattuck-Eidens D; Jhanwar S; Goldgar D; Offit K
    Nat Genet; 1996 May; 13(1):126-8. PubMed ID: 8673092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers.
    Sobol H; Stoppa-Lyonnet D; Bressac-de-Paillerets B; Peyrat JP; Kerangueven F; Janin N; Noguchi T; Eisinger F; Guinebretiere JM; Jacquemier J; Birnbaum D
    Cancer Res; 1996 Jul; 56(14):3216-9. PubMed ID: 8764110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cloning of BRCA1 cDNA and detection of BRCA1 mRNA expression in breast cancer cells].
    Zhou T; Li Y; Liu F; Zhu J; Wang N
    Yi Chuan Xue Bao; 1997 Jun; 24(3):206-11. PubMed ID: 9361452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H; Bitisik O; Akisik E; Cabioglu N; Saip P; Muslumanoglu M; Glendon G; Bengisu E; Ozbilen S; Dincer M; Turkmen S; Andrulis IL; Dalay N; Ozcelik H
    Br J Cancer; 2000 Sep; 83(6):737-42. PubMed ID: 10952777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.